Appointments and advancements for May 7, 2021

New hires and promotions in the biopharma industry, including: Akouos, Brooklyn Immunotherapeutics, Maxwell, Turnstone.

Financings for May 7, 2021

Biopharmas raising money in public or private financings, including: Anebulo, F-star, Gyroscope, Talaris.

In the clinic for May 7, 2021

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Astrazeneca, Corcept, Enanta, Medicenna, Orphazyme, Palisade, Tarsus, Vaxart.

Other news to note for May 7, 2021

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acasti, Anixa, Antibe, Bavarian Nordic, Cantargia, Crispr, Cyxone, Defence, Galapagos, Grace, HTL, HS, Ibio, Inozyme, Kempharm, Molgenie, Nabriva, Nexturn, Nkarta, Oncology Pharma, Ontochem, Regen, Roivant, Rosvivo, Sinovant, Sumitomo, Wuxi, Xcelerate.

Regulatory actions for May 7, 2021

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Beigene, Biontech, Chemocentryx, Eisai, Glaxosmithkline, Merck, Pfizer, Vir.